Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 29/11/2020
SIETES contiene 93170 citas

 
 
 1 a 16 de 16 
Presentar resultados
Seleccionar todas
1. Cita con resumen
Ramasamy SN, Korb-Wells CS, Kannangara DRW, Smith MWH, Wang N, Roberts DM, Graham GG, Williams KM, Day RO. Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012. Drug Saf 2013;36:953-80. [Ref.ID 96270]
2.Enlace a cita original
Abdul MiM, Jiang X, Williams KM, Day RO, Roufogalis BD, Liauw WS, Xu H, Matthias A, Lehmann RP, MacLachlan AJ. Pharmacokinetic and pharmacodynamic interactions of echinacea and policosanol with warfarin in healthy subjects. Br J Clin Pharmacol 2010;69:508-15. [Ref.ID 88440]
4. Cita con resumen
Day RO, Williams KM. Open-label extension studies: do they provide meaningful information on the safety of new drugs?. Drug Saf 2007;30:93-105. [Ref.ID 79290]
5.
Jiang X-M, Williams KM, Liauw WS, Ammit AJ, Roufogalis BD, Duke CC, Day RO, McLachlan AJ. Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol 2005;59:425-32. [Ref.ID 73530]
6.Tiene citas relacionadas
Williams KM. Stereoselective disposition of ibuprofen enantiomers in man. Author's commentary. Br J Clin Pharmacol 2004;58:765-6. [Ref.ID 72365]
7.
Campbell TJ, Williams KM. Therapeutic drug monitoring: antiarrhythmic drugs. Br J Clin Pharmacol 2001;52:21S-34S. [Ref.ID 58308]
8. Cita con resumen
Davies N M, McLachlan AJ, Day DO, Williams KM. Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor. Clin Pharmacokinet 2000;38:225-42. [Ref.ID 49674]
9.
Day RO, McLachlan AJ, Graham GG, Williams KM. Pharmacokinetics of nonsteroidal anti-inflammatory drugs in synovial fluid. Clin Pharmacokinet 1999;36:191-210. [Ref.ID 43938]
10.
Shaffer RA, Brodine SK, Almeida SA, Williams KM, Ronaghy S. Use of simple measures of physical activity to predict stress fractures in young men undergoing a rigorous physical training program. Am J Epidemiol 1999;149:236-42. [Ref.ID 43519]
11.
Campbell TJ, Williams KM. Therapeutic drug monitoring: antiarrhythmic drugs. Br J Clin Pharmacol 1998;46:307-19. [Ref.ID 40140]
12.
Oelkers R, Neupert W, Williams KM, Brune K, Geisslinger G. Disposition and effects of flurbiprofen enantiomers in human serum and blister fluid. Br J Clin Pharmacol 1997;43:145-53. [Ref.ID 31036]
13.
Seideman P, Lohrer F, Graham GG, Duncan MW, Williams KM, Day RO. The stereoselective disposition of the enantiomers of ibuprofen in blood, blister and synovial fluid. Br J Clin Pharmacol 1994;38:221-7. [Ref.ID 22075]
14.
Hughes PH, Brandenburg N, Baldwin DC, Storr CL, Williams KM, Anthony JC, Sheeman DV. Prevalence of substance use among US physicians. JAMA 1992;267:2333-9. [Ref.ID 17453]
15.
Day RO, Graham GG, Williams KM, Brooks PM. Variability in response to NSAIDs: fact or fiction?. Drugs 1988;36:643-51. [Ref.ID 13033]
16.
Lee EJD, Williams KM. Chirality: clinical pharmacokinetic and pharmacodynamic considerations. Clin Pharmacokinet 1990;18:339-45. [Ref.ID 12871]
Seleccionar todas
 
 1 a 16 de 16